Hypertension
Conference Coverage
High CV risk factor burden in young adults a ‘smoldering’ crisis
Cardiovascular risk factors are “unacceptably” high and are increasing among young adults, prompting calls for aggressive preventive measures.
Conference Coverage
Long-term BP reductions with renal denervation not race specific
Long-term blood pressure reductions in the Black patient cohort of the SYMPLICITY renal denervation trial challenge early results.
Conference Coverage
Causal AI quantifies CV risk, providing patient-specific goals
Causal artificial intelligence is showing how specific risk factors can be overcome to avoid cardiovascular events.
Conference Coverage
NUDGE-FLU: Electronic ‘nudges’ boost flu shot uptake in seniors
Two strategies based on electronically delivered letters or “nudges” were found to increase flu shot uptake, compared with usual care, a new study...
Conference Coverage
500 more steps a day tied to 14% lower CVD risk in older adults
New study supports the value of modest but consistent activity to improve heart health.
Conference Coverage
Old drug verapamil may have new use in type 1 diabetes
In randomized trial, the old cardiac agent slowed the destruction of insulin-producing beta cells in youth with new-onset type 1 diabetes.
Latest News
New AHA statement urges focus on CV risk before pregnancy
The emphasis on reducing cardiovascular risk during pregnancy comes too late – the risks have already developed in these patients.
From the Journals
Irregular sleep tied to markers of atherosclerosis
‘Poor sleep is linked with several cardiovascular conditions.’
Latest News
USPSTF backs screening for hypertensive disorders of pregnancy
“Hypertensive disorders of pregnancy are some of the leading causes of serious complications and death for pregnant people.”
Feature
Dapagliflozin gets expanded heart failure indication in Europe
The European Commission has expanded the indication of the SGLT2 inhibitor to include HF with mildly reduced and preserved ejection fraction.
From the Journals
Persistent gaps in drug use by patients with type 2 diabetes
Continuous use of glucose-, BP-, and cholesterol-lowering medications by adults with mainly type 2 diabetes declined in 2005-2019. This may...